Skip to main content


Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Reverse translation of phase I biomarker findings links the activity of angiotensin-(1–7) to repression of hypoxia inducible factor-1α in vascular sarcomas

  • W Jeffrey Petty1, 2, 4Email author,
  • Mebea Aklilu1, 4,
  • Victor A Varela1, 4,
  • James Lovato3, 4,
  • Paul D Savage1, 4 and
  • Antonius A Miller1, 4
BMC Cancer201212:404

DOI: 10.1186/1471-2407-12-404

Received: 2 May 2012

Accepted: 3 September 2012

Published: 11 September 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting

Original Submission
2 May 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
26 Jun 2012 Reviewed Reviewer Report - Galatea Kallergi
26 Jun 2012 Reviewed Reviewer Report - Vijay Kalra
27 Jun 2012 Reviewed Reviewer Report - Christopher Christophi
6 Aug 2012 Author responded Author comments - W. Jeffrey Petty
Resubmission - Version 3
6 Aug 2012 Submitted Manuscript version 3
3 Sep 2012 Editorially accepted
11 Sep 2012 Article published 10.1186/1471-2407-12-404

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

Department of Medicine, Section on Hematology and Oncology, Wake Forest University Health Sciences, Medical Center Boulevard
Department of Cancer Biology, Wake Forest University Health Sciences
Department of Biostatistical Sciences, Wake Forest University Health Sciences
Comprehensive Cancer Center of Wake Forest University, Wake Forest University School of Medicine